Teva Pharmaceuticals Polska sp. z o.o.

Advertising agencies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-04-29
Share capital
1,000,000.00 PLN
Activity description

Teva Pharmaceuticals Polska supplies generic and specialty medicines and manufactures medicines in Krakow. The company runs educational campaigns about migraine and a contest supporting nonprofit initiatives in healthcare.

Registered address
Emilii Plater 53, 00-113 Warszawa, Poland
Branches
  • ul. Osmańska 12, 02-823 Warszawa
  • ul. Mogilska 80, 31-546 Kraków
Website
Social media
Electronic delivery address
AE:PL-57715-78987-WJVSE-16

Financials

Revenue history (in m)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 84 days for 2021). 5 of 6 audited by a statutory auditor.

  • 202513/08/2026
  • 202404/07/2025
  • 202308/07/2024
  • 202211/07/2023
  • 202107/10/2022
  • 202012/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Advertising agencies8 / 3,958
Top <1%
City · Warszawa668 / 56,729
Top 1.2%
Voivodeship · Mazowieckie855 / 76,892
Top 1.1%
Country · Poland2,371 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 97.28mMedianUSD 115.83kAverageUSD 1.12m
Net profit
This companyUSD 1.79mMedianUSD 4.00kAverageUSD 75.38k
Operating costs
This companyUSD 94.60mMedianUSD 100.95kAverageUSD 1.02m
Assets
This companyUSD 47.17mMedianUSD 57.45kAverageUSD 671.79k

Offer

Certifications: GMP

Websites

The company has 8 websites. Traffic on the sites is measured with Google Analytics.

  • teva.plLeki generyczne i specjalistyczne | firma farmaceutyczna Teva
    Google Tag ManagerCloudflare
  • aviomarin.com.plAviomarin, dimenhydramina
    Google Tag ManagerCloudflare
  • calperos.plCalperos PL
    Google Tag ManagerCloudflare

Trademarks

The company holds 17 active trademarks registered with the Polish Patent Office. 80 marks have expired or were not registered. The first mark was filed in 1995.

MarkNumberClassesStatusProtected until
PRONASAL CONTROL (word)Z.5006205Protected Jun 3, 2029
APRESIA (word)Z.4821615Protected Feb 8, 2028
CO-BESPRES PLUS (word)Z.4764025Protected Sep 13, 2027
SAMODZIELNI Program wsparcia i opieki nad pacjentami chorymi na stwardnienie rozsiane Z.4607919, 16, 41, 42, 44, 45Protected Aug 26, 2036
PRONASAL (word)Z.4173385Protected Aug 1, 2033
MarkProtected until
PRONASAL CONTROL (word)Jun 3, 2029
APRESIA (word)Feb 8, 2028
CO-BESPRES PLUS (word)Sep 13, 2027
SAMODZIELNI Program wsparcia i opieki nad pacjentami chorymi na stwardnienie rozsiane Aug 26, 2036
PRONASAL (word)Aug 1, 2033

Job offers

The company has its own careers page: teva.pl/youcareer.

Authorized Representatives

Ewa Agnieszka Królikowska age 48 – President of the Management Board
Leszek Andrzej Ryniak age 61 – Attorney-in-fact (joint)
Michał Ściana age 45 – Attorney-in-fact (joint)
Tatjana Sviderskė age 40 – Management Board Member

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board, or by one member of the management board jointly with a commercial proxy, is required.

Ownership

OwnerSharesShare valueStake
Pliva Hrvatska D.o.o.
1,000$270,124.26100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2003-07-30.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 49,344

MSiG notices

Publication dateEvent
Oct 14, 2016Merger plan
Jan 18, 2016Commercial Companies Code notice
Nov 4, 2015Merger plan

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Fresenius Kabi Polska sp. z o.o.
Zentiva Polska sp. z o.o.
Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.
Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o.
Farmak International sp. z o.o.
Sandoz Polska sp. z o.o.
Orifarm Manufacturing Poland sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
Aristo Pharma sp. z o.o.

Change history

DateEvent
2015-06-17PKD change
2013-02-18PKD change
2010-11-23Switch to PKD 2007
2008-08-21Share capital increase
2003-04-29Entered in the register

FAQ

Last updated: 2026-10-07